There are eight different roles that MHS staff can register for:

1. MHS Prescriber with NPI number - licensed, credentialed, and privileged staff who are authorized to prescribe controlled substances for outpatient use, including, but not limited to, doctors of osteopathy, doctors of medicine, doctors of dental surgery, doctors of podiatric medicine, and nurse practitioners
2. Physician Assistants - licensed (or NCCPA certified), credentialed, and privileged Physician Assistants who are authorized to prescribe controlled substances for outpatient use
3. MHS Pharmacist with NPI number - all pharmacists (outpatient, inpatient, and clinical) with a NPI number; pharmacists without a NPI number may register as a MHS Pharmacy delegate
4. Optometrist - optometrists that are licensed, credentialed, and privileged to prescribe controlled substances for outpatient use
5. Psychologists - psychologists that are licensed, credentialed, and privileged to prescribe controlled substances for outpatient use
6. Medical Interns - interns and residents with a doctor of medicine or doctor of osteopathy degree, but not licensed, credentialed, and privileged to prescribe independently
7. Pharmacy delegate - pharmacy technicians or pharmacists without a NPI number
8. Prescriber delegate - all other staff, to include, but not limited to, corpsmen, independent duty corpsmen, independent medical corpsman, registered nurses, midwives, or other medical staff that cannot register in the MHS PDMP as of the provider roles

MHS Prescribers with NPI, Physician Assistants, and MHS Pharmacists with NPI are required to register in the MHS PDMP, regardless of location (CONUS or OCONUS).

View the PDMP Sharing Spreadsheet for a full listing of roles.

In accordance with DHA-Procedural Instruction 6010.02, providers and pharmacists may apply for access to the state or territory PDMP for which the MTF is located. Providers and pharmacists should consult with servicing legal counsel regarding state or territory PDMP terms and conditions, or other requirements, that may cede disciplinary authority to the state or territory.

In accordance with DHA Procedural Instruction 6010.02, Military Health System Prescription Drug Monitoring Program, providers and pharmacists are required to conduct a PDMP search to the greatest extent possible when there is a suspicion of patient misuse or diversion.

Providers are recommended to check the MHS PDMP:

• When the patient is new to the provider and a DEA Schedule II-IV controlled substance is prescribed
• When a new or renewal DEA Schedule II-IV controlled substance is prescribed for an acute condition
• No less frequently than every 3 months when prescribing controlled substances

Pharmacists, or pharmacy delegates, should check the MHS PDMP when processing a new or renewed DEA Schedule II-IV prescription except:

• When the quantity is prescribed for a 72-hour or less supply
• When the prescription is for a patient under the care of an oncologist or for a terminal patient who has discontinued curative treatment
• At the discretion of the pharmacist based on the patient’s consistent therapy, consistent provider (or provider team), and on-time controlled substance prescription filling

Providers and pharmacists should check the MHS PDMP when a beneficiary is restricted as part of the Prescription Monitoring Program. This includes:

• MHS GENESIS Sole Provider Alert for providers who intend to prescribe a restricted medication
• “LOCKED IN” warning of at the time of prescribing in AHLTA
• Pharmacy warning (in CHCS) or reject (in MHS GENESIS) indicating the beneficiary is locked into a prescriber or pharmacy

Here's the link to DHA Procedural Instruction 6010.02.  All DHA publications can be found in the DHA Publications Library.

When registering for your MHS PDMP account please enter the state of your active professional license in the "Home State" field.

• View your patient's controlled substance prescription history by submitting a Patient Request.
• Select from a broad list of states to include prescriptions paid with cash or processed under other health insurance.
• Approve a delegate to assist with review of your patient reports.
• Use the bulk patient report function to expedite review.
• View your prescribed controlled substance history using your NPI within the MyRx report function.
• Access the MHS User Guide for help navigating the system; under Menu, click AWARxE User Guide.

Contact the Express-Scripts Prescription Drug Monitoring team at mhspmp@express-scripts.com.

For technical support, contact 1-833-275-2050 or submit a new request.

The MHS PDMP is a secure, confidential, and data-encrypted database that requires user authentication before granting access. Similar to other health care data, prescription data within the MHS PDMP is subject to the Health Information Portability and Accountability Act (HIPAA) and is only accessed by authorized users during their professional duties. Furthermore, it complies with the federal standards set by NIST 800-53.

The MHS PDMP is a web-based search tool similar to state PDMPs. The Prescription Monitoring Program is a tool internal to the Military Health System used to identify (and if necessary restrict) patients who potentially have "drug seeking behavior." The TRICARE Pharmacy contractor provides monthly and quarterly PMP reports to specified MTF points of contact, as well as Managed Care Support Contractors, per the TRICARE Operations Manual.

The MHS PDMP began pushing out data on Dec. 20, 2018. On Jan. 16, 2019, Virginia became the first state to share its data with the MHS.

Refer to the current status sharing map above.

Civilian providers who practice in states that have agreements with the Department of Defense will be able to access MHS PDMP data as long as they’re authorized in their state.

Health care providers and pharmacists will need to contact the health care provider who issued the prescription of question, as noted within the PDMP.